Relapsing or Refractory Idiopathic Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome: The Role of Rituximab

Transfusion - United Kingdom
doi 10.1111/j.1537-2995.2010.02763.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Is There a Shared Pathophysiology for Thrombotic Thrombocytopenic Purpura and Hemolytic-Uremic Syndrome?

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2007English

Therapeutic Effects of Rituximab Combined With Cyclophosphamide on Refractory Idiopathic Thrombocytopenic Purpura

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

The Natural History of Refractory Idiopathic Thrombocytopenic Purpura

Blood
BiochemistryImmunologyCell BiologyHematology
2001English

Successful Treatment of Resistant Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome With Autologous Peripheral Blood Stem and Progenitor (CD34+) Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
1999English

Rituximab-Induced Acute and Delayed Serum Sickness in Thrombotic Thrombocytopenic Purpura: The Role of Anti-Rituximab Antibodies

British Journal of Haematology
Hematology
2018English

Pancreatitis Preceding Acute Episodes of Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome: Report of Five Patients With a Systematic Review of Published Reports

Haematologica
Hematology
2007English

Thrombotic Thrombocytopenic Purpura

American Journal of Medicine
Medicine
1959English

Thrombotic Thrombocytopenic Purpura

Laboratory Medicine
BiochemistryClinical Biochemistry
1988English

Thrombotic Thrombocytopenic Purpura (TTP) or Moschowitz Syndrome: A True Hematologic Emergency

Italian Journal of Medicine
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy